MSB 2.70% 95.0¢ mesoblast limited

Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-77

  1. 898 Posts.
    lightbulb Created with Sketch. 2997
    I find it hard to believe all the smart people out there can't see the implications
    of this one product in clinical practice.

    You have something that does a better job than steroids without the side effects. You have something that can save organs that isn't toxic.

    Doctors fight tooth and nail to save organs.


    Off label use is legal and common in the US. According to Stat publication, RA drug Actemra, for example, has been prescribed off-label "for about 60 other conditions for which it has not completed testing for efficacy and safety."

    Reimbursement is the issue, but if cost is set against organ transplant then it would be more likely imo. Even colectomy isn't cheap when you factor in a lifetime of visits to the stoma clinic and treating complications such as pouchitis.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.